- July 7, 2020
The assay is intended to aid in the diagnosis of and identification of carriers for spinal muscular atrophy (SMA) AUSTIN, Texas–(BUSINESS WIRE)– Asuragen, Inc., a
300 Montgomery Street
Suite 1130
San Francisco, CA 94104